These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1743561)

  • 21. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clear cell vaginal adenocarcinoma in young girls. Apropos of a personal case].
    Barrat J; Brocheriou C; Maria B; Darbois Y; Faguer C; Hervet E
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(8):1093-1102. PubMed ID: 1214039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diethylstilbestrol and clear cell vaginal carcinoma. Reappraisal of the epidemiologic evidence.
    McFarlane MJ; Feinstein AR; Horwitz RI
    Am J Med; 1986 Nov; 81(5):855-63. PubMed ID: 3776990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des).
    Robboy SJ; Scully RE; Herbst AL
    J Reprod Med; 1975 Jul; 15(1):13-18. PubMed ID: 1151939
    [No Abstract]   [Full Text] [Related]  

  • 29. Diethylstilbestrol-associated vaginal adenosis followed by clear cell adenocarcinoma.
    Sander R; Nuss RC; Rhatigan RM
    Int J Gynecol Pathol; 1986; 5(4):362-70. PubMed ID: 3643169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stilboestrol and vaginal clear-cell adenocarcinoma syndrome.
    Monaghan JM; Sirisena LA
    Br Med J; 1978 Jun; 1(6127):1588-90. PubMed ID: 656822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clear cell adenocarcinoma of the cervix and vagina. A clinicopathologic study of 21 cases with and without a history of maternal ingestion of estrogens.
    Nordqvist SR; Fidler WJ; Woodruff JM; Lewis JL
    Cancer; 1976 Feb; 37(2):858-71. PubMed ID: 1253110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
    Fetherston WC; Meyers A; Speckhard ME
    Wis Med J; 1972 Feb; 71(2):87-93. PubMed ID: 5060564
    [No Abstract]   [Full Text] [Related]  

  • 33. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal adenocarcinoma in a gravida with prenatal DES exposure.
    Del Castillo H; Rubio PA; Farrell EM
    Int J Gynaecol Obstet; 1978-1979; 16(4):271-3. PubMed ID: 35386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal cancer: an iatrogenic disease?
    Weiss K
    Int J Health Serv; 1975; 5(2):235-51. PubMed ID: 1181297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DES. Effects of in utero exposure.
    Birenboim N
    J Kans Med Soc; 1982 Dec; 83(12):634-8. PubMed ID: 7153637
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of nuclear DNA in vaginal adenosis and clear-cell adenocarcinoma.
    Lewis JL; Nordqvist SR; Richart RM
    Am J Obstet Gynecol; 1973 Mar; 115(6):737-50. PubMed ID: 4688576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.